JNCI-Journal of the National Cancer Institute

Article	Citations
Correction to: TP53 Status as a Determinant of Pro- vs Anti-Tumorigenic Effects of Estrogen Receptor-Beta in Breast Cancer	304
Correction to: RE: Systemic or vaginal hormone therapy after early breast cancer: a Danish observational cohort study	202
Another Weak Link in the Electron Transport Chain: Variants in SUCLG2 and Risk for Pheochromocytoma and Paraganglioma	192
Correction to: ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications	154
Cancer Mortality in Latino Populations by Birthplace and Generation: A Complex Analysis	150
Genomic Determinants of Early Recurrences in Low-Stage, Low-Grade Endometrioid Endometrial Carcinoma	115
Untangling the Relationship Between Clonal Hematopoiesis and Ovarian Cancer Therapies	110
Corrigendum to: Receptivity to a Nurse-Led Symptom Management Intervention among Highly Symptomatic Patients with Cance	103
Corrigendum to: Realizing the Promise of Personalized Colorectal Cancer Screening in Practice	103
BRCA1/2 germline sequencing in children and adolescents with cancer: it is the context that matters	98
The global multiple myeloma incidence and mortality burden in 2022 and predictions for 2045	95
Genome-wide analyses characterize shared heritability among cancers and identify novel cancer susceptibility regions	94
Ethylene oxide emissions and incident breast cancer and non-Hodgkin lymphoma in a US cohort	91
Cancer Hazard Evaluations for Contemporary Needs: Highlights From New National Toxicology Program Evaluations and Methodological Advancements	90
Smoking History as a Potential Predictor of Immune Checkpoint Inhibitor Efficacy in Metastatic Non-Small Cell Lung Cancer	88
RET overexpression leads to increased brain metastatic competency in luminal breast cancer	73
The Survival Impact of Second Primary Lung Cancer in Patients With Lung Cancer	72
Do Cell Phones Cause Brain Tumors? Another Piece of the Puzzle	66
Videos of Sipuleucel-T Programmed T Cells Lysing Cells That Express Prostate Cancer Target Antigens	65
Effect of chronic disease on racial difference in COVID-19–associated hospitalization among cancer patients	63
Mass incarceration and cancer health disparities in the United States: reimagining models of care delivery	60
Response to Huang, Rivero-Hinojosa, Ma, et al	57
Obstetrical and Perinatal Outcomes in Female Survivors of Childhood and Adolescent Cancer: A Population-Based Cohort Study	53
Augmenting randomized clinical trial data with historical control data: Precision medicine applications	53
Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials Methodology	53

Real-World HPV Vaccine Effectiveness Studies: Guideposts for Interpretation of Current and Future Studies	52
COVID-19 Vaccine Among Actively-Treated People With Cancer: A Glimpse Into the Known Unknowns?	49
New and Persistent Sedative-Hypnotic Use After Adjuvant Chemotherapy for Breast Cancer	48
Banning Menthol Cigarettes: The Time Has Come	47
Cancer’s Lasting Financial Burden: Evidence From a Longitudinal Assessment	46
Addressing Diversity, Equity, and Inclusion at the JNCI Journals	46
ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications	45
The long economic shadow of a cancer diagnosis during adolescence or young adulthood	44
Response to Klar and Adams	43
RE: Exploring the cross-cancer effect of circulating proteins and discovering potential intervention targets for 13 site-specific cancers	42
Increasing diversity in clinical trials: demographic trends at the National Cancer Institute, 2005-2020	40
Assessment of Caregivers’ Burden When Caring for Patients With Pancreatic and Periampullary Cancer	39
The Unrelenting Impact of Poverty on Cancer: Structural Inequities Call for Research and Solutions on Structural Determinants	38
Advancing rapid cycle research in cancer care delivery: a National Cancer Institute workshop report	37
Response to Maltoni, Puccetti, Poli, et al.	37
Publisher’s Note	36
RE: Assessment of Ki67 in Breast Cancer: Updated Recommendations from the International Ki67 in Breast Cancer Working Group	36
World Trade Center Rescue and Recovery Workers: Cancer Increases Are Beginning to Emerge	35
Housing Insecurity Among Patients With Cancer	34
Genotypic vs Phenotypic Risk Assessment for Melanoma	34
Benefit vs Harm of Internal Mammary Node Irradiation for Node-Positive Breast Cancer	34
Comparative cost-effectiveness of contemporary treatment strategies for stage IIA seminoma	32
Impact of COVID-19 on 2021 cancer incidence rates and potential rebound from 2020 decline	32
Dyslipidemia and cardiovascular disease among childhood cancer survivors: a St. Jude Lifetime Cohort report	32
Association of Genetic Testing Results With Mortality Among Women With Breast Cancer or Ovarian Cancer	31
Response to Sorscher	31
Improving precision oncology through better designs and reporting of biomarker-driven randomized clinical trials	31
Validating a model for predicting breast cancer and nonbreast cancer death in women aged 55 years and older	31
Can time to deterioration in patient-reported outcomes be a surrogate for overall survival?	31
The Futility of Futility Analyses in Adjuvant Trials in Hormone Receptor–Positive Breast Cancer	31
Childhood body mass index trajectories, adult-onset type 2 diabetes, and obesity-related cancers	30
Cancer Surveillance Opportunities to Meet Prevention and Control Challenges	30
COVID-19 vaccination, infection, and symptoms among cancer survivors in the United States	30
Correlation between tumor size change and outcome in a rare cancer immunotherapy basket trial	30
Low physical function following cancer diagnosis is associated with higher mortality risk in postmenopausal women	30
Reviewers	29
Bilaterality, not multifocality, is an independent risk factor for recurrence in low-risk papillary thyroid cancer	29
Safety of extended interval dosing immune checkpoint inhibitors: a multicenter cohort study	29
Combined individual participant data: highest-level evidence on obesity and colorectal cancer molecular subtypes	29
RE: Systemic or vaginal hormone therapy after early breast cancer: a Danish observational cohort study	28
The National Cancer Institute Funding of Global Research: Lessons Learned and Opportunities Going Forward	27
Response to Krieger	27
Upper age limits for US male human papillomavirus vaccination for oropharyngeal cancer prevention: a microsimulation-based modeling study	27
Correction to: RE: Grade Migration of Prostate Cancer in the United States During the Last Decade	26
Vertical integration in oncology: what does it mean for patients with cancer?	26
Lower survival for surgical treatment of human papillomavirus–related oropharynx cancer at community cancer centers	26
Total neoadjuvant therapy with or without aflibercept in rectal cancer: 3-year results of GEMCAD-1402	26
Disparities in the availability of and access to neuro-oncology trial-supporting infrastructure in the United States	26
Method of primary breast cancer detection and the disease-free interval, adjusting for lead time	26
Re: Deng and Heybati	26

Application of Value Frameworks to the Design of Clinical Trials: The Canadian Cancer Trials Group Experience	26
Li-Fraumeni Syndrome in the Cancer Genomics Era	25
Addressing health-related quality of life inequities in cancer: where do we go from here?	25
Clinical Benefit Scales and Trial Design: Some Statistical Issues	25
Contralateral breast cancer risk with radiation therapy in BRCA mutation carriers: what do we tell patients?	25
Age Is Just a Number: Considerations for Older Adults in Cancer Clinical Trials	24
Familial uveal melanoma and other tumors in 25 families with monoallelic germline MBD4 variants	24
Mental health outcomes in a population-based cohort of patients with prostate cancer	24
Molecular Mechanisms of ARID5B-Mediated Genetic Susceptibility to Acute Lymphoblastic Leukemia	24
The Impact of Breast Density Information or Notification on Women’s Cognitive, Psychological, and Behavioral Outcomes: A Systematic Review	23
Geriatric assessment and management: is decreasing treatment toxicity good enough?	23
Adjuvant endocrine therapy uptake, toxicity, quality of life, and prediction of early discontinuation	23
Systematic investigation of genetically determined plasma and urinary metabolites to discover potential interventional targets for colorectal cancer	23
Defining Multimorbidity and Its Impact in Older United States Veterans Newly Treated for Multiple Myeloma	23
Adherence to National Guidelines on Cervical Screening: A Population-Based Evaluation From a Statewide Registry	23
Leadership Diversity and Development in the Nation’s Cancer Centers	23
Rural–Urban Disparities in Cancer Outcomes: Opportunities for Future Research	22
Response to Wu and Zhang	22
The association of where patients with prostate cancer live and receive care on racial treatment inequities	22
Survivorship after adolescent and young adult cancer: models of care, disparities, and opportunities	22
Medication–Associated Phthalate Exposure and Childhood Cancer Incidence	22
Health insurance among survivors of childhood cancer following Affordable Care Act implementation	22
Editor’s Note to: Targeting Primitive Chronic Myeloid Leukemia Cells by Effective Inhibition of a New AHI-1–BCR-ABL–JAK2 Complex	22
A new perspective on mitigating lung cancer risks through smoking cessation and reduction	21
Stat Bite: Estimated cumulative risk of female breast cancer incidence and mortality (ages 0-74) in 2022	21
Simulating the population impact of interventions to reduce racial gaps in breast cancer treatment	21
The Development of Global Cancer Research at the United States National Cancer Institute	21
Evaluating the sensitivity of EQ-5D-5L in patients with brain metastases: a secondary analysis of NRG CC001	21
Familial adversity: association with discontinuation of adjuvant hormone therapy and breast cancer prognosis	20
Neoadjuvant platinum-based chemotherapy and lymphadenectomy for penile cancer: an international, multi-institutional, real-world study	20
Linkage of individual-patient data confirm protection of prophylactic human papillomavirus vaccination against invasive cervical cancer	20
Survival in Young-Onset Metastatic Colorectal Cancer: Findings From Cancer and Leukemia Group B (Alliance)/SWOG 80405	20
Disparities in Risk of Advanced-Stage Liver Cancer and Mortality by Race and Ethnicity	20
PD-L1 Immunohistochemistry Assay Comparison in Atezolizumab Plus nab-Paclitaxel–Treated Advanced Triple-Negative Breast Cancer	20
BRCA1/2 and Endometrial Cancer Risk: Implications for Management	19
Prevalence of anal cytology screening among persons with HIV and lack of access to high-resolution anoscopy at HIV care facilities	19
When the somatic genome informs the germline: the example of TP53	19
Comparing the efficacy and safety of first-line treatments for chronic lymphocytic leukemia: a network meta-analysis	19
Surgical Care for Older Adults: The Importance of Patient-Centered Outcomes in Daily Practice	19
Response to Khouri and Suissa	19
Comparison of Treatments for Nonmetastatic Castration-Resistant Prostate Cancer: Matching-Adjusted Indirect Comparison and Network Meta-Analysis	19
Reducing ovarian cancer mortality through screening: an impossible dream?	19
Evidence Gaps in Cancer Survivorship Care: A Report From the 2019 National Cancer Institute Cancer Survivorship Workshop	19
Mediators of Racial Disparities in Heart Dose Among Whole Breast Radiotherapy Patients	19
Nitrogen-based Bisphosphonate Use and Ovarian Cancer Risk in Women Aged 50 Years and Older	19
Adverse birth outcomes of adolescent and young adult women diagnosed with cancer during pregnancy	19
RE: Association of metformin use and cancer incidence: a systematic review and meta-analysis	19
Cancer mortality rates by racial and ethnic groups in the United States, 2018-2020	18
The evolution of NCI’s Health Information National Trends Survey: methods, data, and future directions	18
Correction to: Longitudinal e-Cigarette and Cigarette Use Among US Youth in the PATH Study (2013–2015)	18
Physical activity, metabolites, and breast cancer associations	18
Response to Liu, Xiao, Liu, et al.	18
The impact of multidisciplinary cancer conferences on overall survival: a meta-analysis	18
Modeling disparities in colorectal cancer outcomes: colonoscopy follow-up and quality are key	18
Radiation dose, schedule, and novel systemic targets for radio-immunotherapy combinations	18
The National Cancer Institute clinical trials planning meeting to address gaps in observational and intervention trials for cancer-related cognitive impairment	18
Effect of chemotherapy and surgery timing on mortality in upper and lower extremity osteosarcoma	18
Trends in breast cancer–specific death by clinical stage at diagnoses between 2000 and 2017	18
Inflammatory and insulinemic dietary patterns and risk of endometrial cancer among US women	17
RE: Use of artificial intelligence for cancer clinical trial enrollment	17
Risk of Pancreatic Cancer in the Long-Term Prospective Follow-Up of Familial Pancreatic Cancer Kindreds	17
Addressing Social Determinants of Health: Now Is the Time	17
Factors associated with timely COVID-19 vaccination in a population-based cohort of patients with cancer	16
Determining PD-L1 Status in Patients With Triple-Negative Breast Cancer: Lessons Learned From IMpassion130	16
RE: The impact of multidisciplinary cancer conferences on overall survival: a meta-analysis	16
NCI Rectal-Anal Task Force consensus recommendations for design of clinical trials in rectal cancer	16
Predictive Role of CD36 Expression in HER2-Positive Breast Cancer Patients Receiving Neoadjuvant Trastuzumab	16
The association of health-care contact days with physical function and survival in CCTG/AGITG CO.17	16
Annual Report to the Nation on the Status of Cancer, Part 1: National Cancer Statistics	16
Helicobacter pylori Modulated Host Immunity in Gastric Cancer Patients With S-1 Adjuvant Chemotherapy	15
Body mass index and molecular subtypes of colorectal cancer	15
Counts, incidence rates, and trends of pediatric cancer in the United States, 2003-2019	15
Long-term aspirin use and cancer risk: a 20-year cohort study	15
Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C	15
Body Mass Index and Risk of Second Cancer Among Women With Breast Cancer	15
Medical Financial Hardship in Survivors of Adolescent and Young Adult Cancer in the United States	15
Assessing the effect of the COVID-19 pandemic on 1-year cancer survival in the United States	15
The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis	15
Real-World Use of Bone-Modifying Agents in Metastatic Castration-Sensitive Prostate Cancer	15
Human papillomavirus–associated anal squamous cell carcinoma: sociodemographic, geographic, and county-level economic trends in incidence rates—United States, 2001-2019	15

Obligate and Potential Precursors of Melanoma	15
Metabolically (un)healthy obesity and risk of obesity-related cancers: a pooled study	14
Risk factors for breast cancer subtypes by race and ethnicity: a scoping review	14
Deciphering the sex gap in global life expectancy: the impact of female-specific cancers 1990-2019	14
Recommendations for Epstein-Barr virus–based screening for nasopharyngeal cancer in high- and intermediate-risk regions	14
The risk and benefit profiles of US-eligible lung cancer screening attendees vs nonattendees	14
Cancers with epidemiologic signatures of viral oncogenicity among immunocompromised populations in the United States	14
Influence of endoxifen on mammographic density: results from the KARISMA-Tam trial	14
Glucagon-like peptide-1 receptor agonists and pancreatic cancer risk: target trial emulation using real-world data	14
Inflammation, physical activity, and disease-free survival in stage III colon cancer: Cancer and Leukemia Group B–Southwest Oncology Group 80702 (Alliance)	14
Gauging the efficacy of multicancer screening: the road ahead may be long and bumpy	14
Association of immunoglobulin E levels with glioma risk and survival	13
Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: clinical insights and genomic features from a large contemporary cohort	13
Response to Liu and Zhang	13
Race and clinical outcomes in hormone receptor-positive, HER2-negative, node-positive breast cancer in the randomized RxPONDER trial	13
Health-related quality of life with pembrolizumab plus chemotherapy vs placebo plus chemotherapy for advanced triple-negative breast cancer: KEYNOTE-355	13
Evaluating a blood test for colon cancer screening: how simulation modeling can inform clinical policy making and research	13
Risk factors for second primary breast cancer by laterality, age, and race and ethnicity	13
Long-term survival across Breslow thickness categories: findings from a population-based study of 210 042 Australian melanoma patients	13
Supporting evidence in phase 2 cancer trial protocols: a content analysis	13
Germline pathogenic variants in neuroblastoma patients are enriched in BARD1 and predict worse survival	13
Assessment of intermediate-term mortality following pancreatectomy for cancer	13
Paternity After Treatment for Testicular Germ Cell Cancer: A Danish Nationwide Population-Based Cohort Study	12
Changes in cancer-related mortality during the COVID-19 pandemic in the United States	12
Centering patients with advanced cancer includes supporting their caregivers	12
The intratumor microbiome is associated with microsatellite instability	12
Retraction and Replacement of: Increasing power in screening trials by testing control-arm specimens: application to multicancer detection screening	12
Long-term behavioral symptom clusters among survivors of early-stage breast cancer: Development and validation of a predictive model	12
Understanding risk factors for endometrial cancer in young women	12
Transoral Robotic Surgery for Recurrent Tumors of the Upper Aerodigestive Tract (RECUT): An International Cohort Study	12
Targeted eHealth Intervention to Reduce Breast Cancer Survivors’ Fear of Recurrence: Results From the FoRtitude Randomized Trial	12
RE: Adjuvant Aromatase Inhibitors or Tamoxifen Following Chemotherapy for Perimenopausal Breast Cancer Patients	12
Racial and socioeconomic disparities in non–small cell lung cancer molecular diagnostics uptake	12
Evaluating clinical utility of comprehensive genomic profiling—challenges and opportunities	12
Drug and biomarker tissue levels in a randomized presurgical trial on exemestane alternative schedules	12
Essentialism and Exclusion: Racism in Cancer Risk Prediction Models	12
An Artificial Intelligence System for the Detection of Bladder Cancer via Cystoscopy: A Multicenter Diagnostic Study	12
Disparities in parental distress in a multicenter clinical trial for pediatric acute lymphoblastic leukemia	12
Uptake of breast cancer screening practices in low- and middle-income countries: a systematic review and meta-analysis	12
Exercise and Nutrition to Improve Cancer Treatment-Related Outcomes (ENICTO)	12
Design of phase II oncology trials evaluating combinations of experimental agents	11
An essential goal within reach: attaining diversity, equity, and inclusion for the Journal of the National Cancer Institute journals	11
Decreasing incidence of conjunctival squamous cell carcinoma in people with HIV in South Africa	11
Corrigendum to: p16/ki67 and E6/E7 mRNA Accuracy and Prognostic Value in Triaging HPV DNA-Positive Women	11
Combining antivascular endothelial growth factor and anti-epidermal growth factor receptor antibodies: randomized phase II study of irinotecan and cetuximab with/without ramucirumab in second-line col	11
Reply to Bertucci, De Nonneville, and Finetti	11
You Get What You Pay For: Breast MRI Screening of Women With Dense Breasts Is Cost-effective	11
Response to Nahshon and Lavie	11
Aspirin and Primary Prevention of Colorectal Cancer: A Still-Evolving Story	11
RE: COVID-19 severity by vaccination status in the NCI COVID-19 and Cancer Patients Study (NCCAPS)	11
RE: Systemic or vaginal hormone therapy after early breast cancer: a Danish Observational Cohort Study	11
Common analgesics and ovarian cancer survival: the Ovarian cancer Prognosis And Lifestyle (OPAL) Study	10
Geriatric assessment and quality of life for 2 years in older patients with head and neck cancer	10
Oral Contraceptives and BRCA Cancer: A Balancing Act	10
Predictive Biomarkers: Progress on the Road to Personalized Cancer Immunotherapy	10
One Size Does Not Fit All: The Need for Population-Specific Palliative Care Interventions	10
Emerging insights into ethnic-specific TP53 germline variants	10
Identification of Mitochondrial DNA Variants Associated With Risk of Neuroblastoma	10
Impacts of an Opioid Safety Initiative on US Veterans Undergoing Cancer Treatment	10
Cancer risk in patients with diverticular disease: A nationwide cohort study	10
Fertility-preserving treatments for endometrial intraepithelial neoplasia: the known unknowns	10
Putting patients first to redefine prostate cancer classifications	10
A predictor of response in HER2+ breast cancer—at last!	10
Racial and ethnic disparities in mortality among breast cancer survivors after a second malignancy	10
Response to Wernly, Datz, and Wernly	10
RE: Risks of depression, anxiety, and suicide in partners of men with prostate cancer: a national cohort study	10
Editor’s Note on: Structural Basis for Depletion of Heat Shock Protein 90 Client Proteins by Deguelin	9
Additive effects of TPMT and NUDT15 on thiopurine toxicity in children with acute lymphoblastic leukemia across multiethnic populations	9
Associations Between Glycemic Traits and Colorectal Cancer: A Mendelian Randomization Analysis	9
A framework for assessing interactions for risk stratification models: the example of ovarian cancer	9
Probing the relevance of BRCA1 and BRCA2 germline pathogenic variants beyond breast and ovarian cancer	9
Lung cancer screening with low-dose computed tomography—where do we go from here?	9
RE: NDRG1 in Aggressive Breast Cancer Progression and Brain Metastasis	9
Target trial emulation to assess real-world efficacy in the Epidemiological Strategy and Medical Economics metastatic breast cancer cohort	9
Justification, margin values, and analysis populations for oncologic noninferiority and equivalence trials: a meta-epidemiological study	9
Response to Haiman, Kote-Jarai, Darst et al.	9
Diabetes and Cancer: Unraveling the Complexity	9
RE: Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study	9
Impact of knowledge of human papillomavirus positivity on cervical cytology performance in Latin America	9
Expanding the list of cancers recognized to be caused by infectious agents	9
SRGN-Triggered Aggressive and Immunosuppressive Phenotype in a Subset of TTF-1–Negative Lung Adenocarcinomas	9
Variation in Cardiac Dose Explains a “Fraction” of the Disparities Among Breast Cancer Patients	9
Association of Genetic Ancestry With Terminal Duct Lobular Unit Involution Among Healthy Women	9
Persistence of Chemotherapy-Induced Peripheral Neuropathy Despite Vincristine Reduction in Childhood B-Acute Lymphoblastic Leukemia	8
Correction to: Correlation between tumor size change and outcome in a rare cancer immunotherapy basket trial	8
Real-World Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer	8
Targeting fusion oncoproteins in childhood cancers: challenges and future opportunities for developing therapeutics	8
Cost-effectiveness analysis of 7 treatments in metastatic hormone-sensitive prostate cancer: a public-payer perspective	8
Cancer Mortality Patterns by Birthplace and Generation Status of Mexican Latinos: The Multiethnic Cohort	8
A national evaluation of adjuvant chemotherapy in pT4N0M0 colon cancer from the National Cancer Database	8
Cellular Telephone Use and the Risk of Brain Tumors: Update of the UK Million Women Study	8
Reaffirming our values: the Journal of the National Cancer Institute’s commitment to excellence and society	8
Design and reporting of phase III oncology trials with prospective biomarker validation	8
Patient-Reported Outcomes and Long-Term Nonadherence to Aromatase Inhibitors	8
Exposure to polycyclic aromatic hydrocarbons, volatile organic compounds, and tobacco-specific nitrosamines and incidence of esophageal cancer	8